NCT06409585View on ClinicalTrials.gov

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

RecruitingOBSERVATIONAL
Enrollment

290

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

August 1, 2027

Study Completion Date

January 1, 2028

Conditions
Heart Failure With Preserved Ejection FractionHypertrophic CardiomyopathyCardiac SarcoidosisHypertensive Heart DiseaseTako Tsubo CardiomyopathyArrhythmogenic Right Ventricular Cardiomyopathy 1Myocarditis
Interventions
DIAGNOSTIC_TEST

68Ga-FAPI or 18F-AlF-FAPI cardiac PET-MR

200MBq of the above named radiotracer will be administered for PET-MR

DIAGNOSTIC_TEST

Echocardiogram

Echocardiogram at baseline and 1 year follow-up

DIAGNOSTIC_TEST

Cardiac MRI

Cardiac MRI at 1 year

Trial Locations (1)

EH16 5RR

RECRUITING

University of Edinburgh, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER